423 filings
PRE 14A
AVTX
Avalo Therapeutics Inc
Preliminary proxy
7 Jun 24
7:01am
S-3
AVTX
Avalo Therapeutics Inc
Shelf registration
6 Jun 24
4:03pm
8-K/A
AVTX
Avalo Therapeutics Inc
3 Jun 24
Index to Financial Statements
7:20am
8-K
AVTX
Avalo Therapeutics Inc
23 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
10-Q
2024 Q1
AVTX
Avalo Therapeutics Inc
Quarterly report
13 May 24
7:33am
8-K
dfh44gnte4k01
13 May 24
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
7:30am
D
yhgjt2t7ew09zf2g2x
9 Apr 24
$199.98 mm in equity / options, sold $130.60 mm, 25 investors
4:58pm
8-K
euj n5v1wmhv2hi
29 Mar 24
Avalo Reports 2023 Financial Results and Provides Business Updates
4:02pm
DEFA14A
7eke0
28 Mar 24
Additional proxy soliciting materials
6:26am
8-K
phab7sm
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
8-K
yxtsaa jo83
31 Jan 24
Other Events
4:01pm
8-K
98yn1ntl
28 Dec 23
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
5:05pm
8-K
btqkew w9drh0d6u7
20 Dec 23
Submission of Matters to a Vote of Security Holders
4:01pm
DEFA14A
j50m0rabu n7p
7 Dec 23
Additional proxy soliciting materials
7:02am
8-K
cpxrloclqax2jt pxh
7 Dec 23
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
7:01am
8-K
yiikw5
16 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:15am
8-K
qx3cuf
9 Nov 23
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
7:04am
8-K
z1va8lt1
31 Oct 23
Avalo Completes Divestiture of AVTX-800 Series
7:21am